Frequent early cognitive impairment in both pediatric MS and MOGAD

Authors:

Abstract
Background: Studies on early cognitive impairment (CI) in pediatric multiple sclerosis (MS) are heterogeneous and data on pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are scarce. Objectives: To evaluate early cognitive dysfunction in both diseases and delineate disease-specific neurocognitive profiles. Methods: A cross-sectional study of children with MS and MOGAD assessed neurocognition within 2 years after disease onset using a comprehensive test battery. Test results were converted to Z -scores. CI was defined as Z -scores below −1.5 in ⩾2 domains. Children were compared by CI status and domain deficits quantified with composite Z -scores. Results: Sixty-seven participants were analyzed (MS n = 36, MOGAD n = 31). Despite normal full-scale intelligence quotient, 47% of MS children and 43% of MOGAD children (acute disseminated encephalomyelitis excluded) met criteria for CI. Domain-specific impairments were prominent in complex attention, with significantly reduced composite Z -scores (MS: −1.24, p < 0.001; MOGAD: −1.12, p = 0.019). MS children additionally showed lower scores on tasks of visuospatial processing and visual memory. Only fatigue was significantly associated with the presence of CI (PedsQL fatigue Z -score: −2.61 vs −0.75, p = 0.005). Conclusion: In both pediatric MS and MOGAD, early CI is prevalent with difficulties in complex attention. Visuospatial cognition appears to be an additional vulnerable area for children with MS.
Funding Information
  • Stichting Vrienden van het Sophia
  • Nationale Postcode Loterij
  • MS research Stichting (project number 21-1136)

This publication has 30 references indexed in Scilit: